Printer Friendly
The Free Library
22,695,004 articles and books

HTG Announces Availability of 96 Max Gene Expression Assay at American Association of Cancer Research (AACR) Annual Meeting.

DENVER -- HTG HTG

In currencies, this is the abbreviation for the Haitian Gourde.

Notes:
The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion.
, Inc., provider of the quantitative Nuclease Protection Assay A nuclease protection assay is a laboratory test used in biochemistry and genetics to identify individual RNA molecules in a heterogeneous RNA sample extracted from cells. The technique can identify one or more RNA molecules of known sequence even at low total concentration.  (qNPA[TM]) today announced the launch of the quantitative Nuclease protection assay (qNPA[TM]) 96 Max gene expression assay at the American Association American Association refers to one of the following professional baseball leagues:
  • American Association (19th century), active from 1882 to 1891.
  • American Association (20th century), active from 1902 to 1962 and 1969 to 1997.
 of Cancer Research (AACR AACR American Association for Cancer Research
AACR Anglo-American Cataloging Rules
AACR Australasian Association of Cancer Registries
AACR African Armed Conflicts Resolved
) annual meeting. This new testing configuration enables the measurement of 46 genes in a 96 well Array Plate. The offering provides researchers with the ability to analyze a larger number of gene signatures for research and clinical validation work in academic and translational medicine translational medicine Molecular medicine The constellation of activities which seek to translate the science of gene discovery, gene transfer, and functional genomics into gene-targeted therapies .

This 96 Max gene expression automated assay is based on HTG's proven qNPA ArrayPlate technology platform, which allows researchers to investigate a larger set of genes with greater precision than traditional gene expression assays. The technology allows academic researchers to quickly and efficiently measure gene expression levels of mRNA and miRNA in a variety of cell and tissue types including formalin-fixed, paraffin-embedded (FFPE FFPE Formalin-Fixed, Paraffin-Embedded (tissue)
FFPE Fédération de la Fonction Publique Européenne (Staff Representation at the European Commission) 
) samples. The technology is ideal for detecting small, yet important changes in gene expression levels which other gene expression platforms cannot reliably detect.

"HTG's new assay offering enables our academic researchers, who are conducting clinical and basic research, to essentially unlock information from sample types that were previously very challenging and near impossible to evaluate accurately," said BJ Kerns, VP Strategic Marketing and Business Development, HTG. "This is yet another expansion of our ArrayPlate platform. We devised this unique testing format to accommodate the needs of academic researchers who are evaluating tumor stratification, pathway and outcome schemes, as well as chemosensitivity."

About HTG

Privately-held HTG is based in Tucson, Arizona. Investors in the company include Solstice solstice (sŏl`stĭs) [Lat.,=sun stands still], in astronomy, either of the two points on the ecliptic that lie midway between the equinoxes (separated from them by an angular distance of 90°).  Capital, Valley Ventures, Merck Capital Ventures, Village Ventures and Arcturus Capital. Additional information is available at www.htgenomics.com.
COPYRIGHT 2009 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2009 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Apr 20, 2009
Words:279
Previous Article:Mavent, QuestSoft Alliance Helps Lenders Meet Secondary Market Demands.
Next Article:Carl Lamm Holding AB: New Date for Interim Report Regarding Q3, January-March 2009.
Topics:

Terms of use | Copyright © 2014 Farlex, Inc. | Feedback | For webmasters